• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0302
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombosis (2100); Atrial Perforation (2511)
Event Date 03/22/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The customer reported the device was discarded.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Event Description
This is filed for thrombus and atrial septal defect, requiring intervention.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with a grade of 4+.As the steerable guide catheter (sgc) crossed the transseptal puncture into the left atrium, a fluttering structure was noted, that was felt to be thrombus.Two clips were implanted and the mr was reduced to grade 1+.An atrial septal defect (asd) occluder was implanted as treatment of the asd.The event resolved on (b)(6) 2019.There was no additional information provided.
 
Manufacturer Narrative
Internal file number: (b)(4).Patient code 2511-labeled: removed.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of thrombosis is listed in the mitraclip system instructions for use, as a known possible complication associated with mitraclip procedures.Based on the information reviewed, a conclusive cause for the thrombosis could not be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
Subsequent to the initial 30-day medwatch report, additional information was provided, indicating that the atrial septal defect (asd) occluder was not implanted as treatment of an asd.The asd occluder was implanted as treatment of the thrombus, preventing possible translocation of the thrombus from the right atrium through the asd to the left atrium.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8542404
MDR Text Key142876320
Report Number2024168-2019-03212
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 06/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/07/2020
Device Catalogue NumberSGC0302
Device Lot Number90107U103
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/01/2019
Initial Date FDA Received04/23/2019
Supplement Dates Manufacturer Received06/03/2019
Supplement Dates FDA Received06/14/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
IMPLANTED MITRACLIPS (X2)
Patient Outcome(s) Required Intervention;
Patient Age79 YR
Patient Weight70
-
-